IPSAS 41
Active
Financial Instruments
Establishes principles for financial reporting of financial assets and financial liabilities, covering recognition, derecognition, classification, measurement, impairment, hedge accounting, and presentation. Replaces almost all of IPSAS 29. Effective 1 January 2023.
Active Standard
IPSAS 41 Financial Instruments is the current, active standard issued by the IPSASB for recognition, classification, measurement, impairment, derecognition, and hedge accounting of financial assets and financial liabilities. Effective for periods beginning on or after 1 January 2023. It replaces almost all of IPSAS 29 Financial Instruments: Recognition and Measurement.
IPSAS 41 is the IPSASB's adaptation of IFRS 9 Financial Instruments for the public sector – retaining the core classification, impairment, and hedge-accounting models while adding public-sector-specific guidance for concessionary loans, financial guarantees at nil/nominal consideration, equity instruments from non-exchange transactions, and fair value measurement. The standard also retains additional fair value guidance carried over from IPSAS 29.
1
Objective, Scope & Out-of-Scope Instruments (paras. 1–9)
Objective
Establishes principles for financial reporting of financial assets and liabilities that present relevant, useful information for assessing the AMOUNT, TIMING, and UNCERTAINTY of an entity's future cash flows. This is the successor to almost all of IPSAS 29's original content – see that Standard's own poster for its narrow surviving legacy hedge-accounting role.
Key exclusions (para. 2)
Equity-method interests (IPSAS 34/35/36) – though derivatives on them, and the HOLDER's own equity instruments, generally stay in scope Lease rights/obligations (IPSAS 43) – EXCEPT finance/operating lease receivables (derecognition + impairment), lessee lease liabilities (derecognition only), and embedded lease derivatives Employee benefit plan rights/obligations (IPSAS 39) The entity's OWN equity instruments (IPSAS 28) – though holders still apply IPSAS 41 Insurance contracts (except financial guarantee contracts, and embedded non-insurance derivatives) Initial recognition/measurement of IPSAS 47 revenue transaction rights/obligations – though IMPAIRMENT still applies Service concession grantor rights/obligations (IPSAS 32) – except the financial liability model's DERECOGNITION provisions
2
Definitions (para. 9)
Credit & measurement vocabulary
Amortized cost
Initial measurement, less principal repayments, plus/minus cumulative effective-interest amortization, adjusted for any loss allowance.
Credit-impaired financial asset
One where a detrimental event has already occurred – significant financial difficulty, default, a lender concession, probable bankruptcy, or a deep-discount purchase reflecting incurred losses.
Credit loss
The difference between contractual cash flows due and cash flows expected to be received, discounted at the original effective interest rate.
Instrument & interest vocabulary
Derivative
A contract whose value changes with an underlying variable, requires little/no initial net investment, and settles at a future date – all THREE features required.
Effective interest rate
The rate that exactly discounts estimated future cash flows through the expected life to the gross carrying amount (assets) or amortized cost (liabilities).
12-month expected credit losses
The portion of lifetime expected credit losses from default events possible within 12 months of the reporting date.
3
Recognition & Initial Measurement (paras. 10–11, 57–60)
Recognition – becoming a party to the contract
Recognize a financial asset/liability when, and only when, the entity becomes PARTY to the instrument's contractual provisions
Regular way purchases/sales use EITHER trade date OR settlement date accounting consistently (para. 11).
Initial measurement – fair value plus/minus transaction costs
Fair value ± transaction costs directly attributable to acquisition/issue – EXCEPT for instruments measured at fair value through surplus or deficit, where transaction costs are EXPENSED immediately
Practical expedient: short-term receivables WITHOUT a significant IPSAS 47 financing component may be measured at TRANSACTION CONSIDERATION instead; short-term payables similarly, if discounting's effect is immaterial (para. 60).
4
Derecognition of Financial Assets – the Risks-and-Rewards Framework (paras. 12–20)
Two derecognition triggers (para. 14)
Contractual rights to the cash flows EXPIRE or are WAIVED, OR The asset is TRANSFERRED, and that transfer qualifies for derecognition
"Pass-through" arrangements (retaining contractual rights but assuming an obligation to remit to eventual recipients) are treated as a transfer ONLY if three strict conditions hold: no obligation to pay unless equivalent amounts are collected; prohibited from selling/pledging the original asset; and an obligation to remit WITHOUT material delay, with no reinvestment right beyond short-term cash equivalents (para. 16).
The three-way risks-and-rewards test (para. 17)
Risks/rewards outcomeTreatment
Transfers SUBSTANTIALLY ALLDerecognize; separately recognize any retained/created rights and obligations
Retains SUBSTANTIALLY ALLCONTINUE recognizing the asset in full
Neither transfers nor retains substantially allTest CONTROL: retained control → continue recognizing to the extent of CONTINUING INVOLVEMENT; no retained control → derecognize
5
Derecognition of Financial Liabilities (paras. 35–38)
Extinguishment – discharged, waived, canceled, or expired
Remove a financial liability when, and only when, it is EXTINGUISHED
An exchange of debt instruments with SUBSTANTIALLY DIFFERENT terms – or a SUBSTANTIAL modification of existing terms, whether or not from the debtor's financial difficulty – is treated as EXTINGUISHING the old liability and recognizing a NEW one (para. 36).
The extinguishment gain/loss, and partial repurchase
Gain/loss = carrying amount extinguished − consideration paid (including non-cash assets/liabilities assumed) → surplus or deficit
Where a lender WAIVES an obligation, or a third party assumes it as a non-exchange transaction, IPSAS 47 applies instead (para. 37). PARTIAL repurchases allocate the previous carrying amount between the retained and derecognized portions, by RELATIVE FAIR VALUE at the repurchase date (para. 38).
6
Classification of Financial Assets – Management Model & SPPI Tests (paras. 39–44)
Three categories, driven by TWO tests together
CategoryManagement modelCash flow characteristics
Amortized costHOLD to collect contractual cash flowsSOLELY payments of principal and interest (SPPI) on outstanding principal
Fair value through net assets/equityBOTH collect contractual cash flows AND sellSPPI
Fair value through surplus or deficitResidual – everything elseResidual – everything else, including equity instruments
"Principal" = the financial asset's fair value AT initial recognition. "Interest" = consideration for the time value of money, credit risk, other basic lending risks/costs, and a profit margin (para. 43). An IRREVOCABLE election is available for equity instruments otherwise defaulting to fair value through surplus/deficit, to instead present fair value changes in net assets/equity (para. 42, §13).
The fair value option override – eliminating an accounting mismatch
Even where amortized cost or FVNA/E would otherwise apply, an entity MAY irrevocably designate a financial asset at fair value through surplus or deficit at initial recognition, IF doing so eliminates or significantly reduces an accounting MISMATCH
A mismatch arises from measuring related assets/liabilities, or recognizing their gains/losses, on DIFFERENT bases (para. 44).
7
Classification of Financial Liabilities (paras. 45–46)
Default: amortized cost – four exceptions (para. 45)
Fair value through surplus or deficit (incl. derivative liabilities) – measured at FAIR VALUE Transferred-asset liabilities that FAIL derecognition, or continuing-involvement liabilities FINANCIAL GUARANTEE CONTRACTS – higher of the loss allowance (§10) and initial recognition amount, less cumulative IPSAS 47 revenue recognized Below-market LOAN COMMITMENTS – same "higher of" measurement as guarantees Contingent consideration from an IPSAS 40 public sector combination – fair value, changes to surplus or deficit
The fair value option for liabilities (para. 46)
Irrevocable designation at fair value through surplus or deficit, EITHER to eliminate an accounting mismatch, OR where a group of assets/liabilities is managed and evaluated on a fair value basis under a DOCUMENTED risk management/investment strategy, reported that way to KEY MANAGEMENT PERSONNEL (IPSAS 20).
8
Reclassification & Embedded Derivatives (paras. 47–56)
Reclassification – RARE, and only for a genuine model change
Reclassify financial ASSETS only when the entity CHANGES its management model – liabilities are NEVER reclassified
A hedging-relationship change (an instrument starting/stopping being a hedge) is explicitly NOT a reclassification (paras. 54–56).
Embedded derivatives – bifurcation for non-financial-asset hosts
Financial ASSET host → apply the WHOLE-CONTRACT classification test (§6) – no separate bifurcation NON-asset host (e.g. a liability or lease host) → separate the embedded derivative ONLY IF: its economics AREN'T closely related to the host's; a standalone instrument with the same terms would itself be a derivative; AND the hybrid isn't already fair-valued through surplus/deficit
If separation is required but the embedded derivative can't be measured reliably on its own, the ENTIRE hybrid contract is designated at fair value through surplus or deficit instead (paras. 52–53).
9
Subsequent Measurement – Amortized Cost & the Effective Interest Method (paras. 61–69)
Three measurement destinations for assets, one for liabilities
Financial assets: amortized cost, fair value through net assets/equity, or fair value through surplus or deficit (para. 61) – per the §6 classification. Financial liabilities: per §7's classification. Amortized-cost and FVNA/E assets are BOTH subject to the impairment requirements (§10) (para. 62).
The effective interest method
Interest revenue = effective interest rate × the instrument's GROSS carrying amount – EXCLUDING expected credit losses from the rate calculation itself
The effective interest rate discounts estimated future cash flows (considering prepayment/extension/call options, but NOT credit losses) to the gross carrying amount (assets) or amortized cost (liabilities), including all fees/points integral to the rate.
10
Impairment – the Expected Credit Loss Model (paras. 73–83, 90)
The two-bucket general approach
Credit risk has increased SIGNIFICANTLY since initial recognition → measure the loss allowance at LIFETIME expected credit losses
No significant increase → measure at 12-MONTH expected credit losses only
Applies to amortized-cost and FVNA/E assets, lease receivables, loan commitments, and financial guarantee contracts (para. 73). For FVNA/E assets, the loss allowance goes to NET ASSETS/EQUITY – it does NOT reduce the SOFP carrying amount (para. 74). The gain/loss adjusting the allowance to the required amount hits SURPLUS OR DEFICIT (para. 80).
Assessing "significant increase" – the 30-day rebuttable presumption
Compare DEFAULT RISK at the reporting date vs. at initial recognition – NOT the change in expected loss amount itself (para. 81) LOW credit risk at the reporting date → may ASSUME no significant increase (para. 82) REBUTTABLE PRESUMPTION: credit risk has increased significantly once payments are >30 DAYS past due – rebuttable only with reasonable, supportable evidence obtainable without undue cost/effort (para. 83) Forward-looking information takes priority over past-due data WHEREVER available without undue cost/effort
Measuring expected credit losses (para. 90)
An UNBIASED, PROBABILITY-WEIGHTED amount, evaluating a RANGE of possible outcomes The TIME VALUE OF MONEY Reasonable and supportable information available without undue cost or effort at the reporting date, including FORWARD-LOOKING data
11
Impairment – Simplified Approach, Modified & Purchased Credit-Impaired Assets (paras. 84–89)
Simplified approach – ALWAYS lifetime, no staging needed
Trade/binding-arrangement receivables (IPSAS 47) WITHOUT a significant financing component → ALWAYS lifetime expected credit losses, mandatorily
WITH a significant financing component, or LEASE receivables (IPSAS 43) → lifetime ECL is an ACCOUNTING POLICY CHOICE, electable separately for trade vs. lease receivables, and for finance vs. operating lease receivables (paras. 87–88).
Modified assets, and purchased/originated credit-impaired assets
MODIFIED (but not derecognized) cash flows → compare default risk at the reporting date (using MODIFIED terms) against default risk at initial recognition (using ORIGINAL terms) (para. 84) PURCHASED OR ORIGINATED credit-impaired assets – already impaired at acquisition – recognize only the CUMULATIVE CHANGE in lifetime ECL since initial recognition; even FAVORABLE changes are recognized as a gain, even below the amount built into the original cash flow estimates (paras. 85–86)
The purchased/originated credit-impaired rules do NOT apply to short-term receivables (para. 89).
12
Concessionary Loans – a Public-Sector-Specific Model (paras. AG118–AG126)
What makes them distinctive
Loans granted/received at BELOW-MARKET terms – loans to developing countries, small farms, student loans, low-income housing loans. The INTENTION from the outset is to provide/receive resources below market terms – this is what distinguishes a concessionary loan from a later WAIVER of a loan originally made at market terms (para. AG119–AG120).
Concessionary vs. originated credit-impaired – a substance test
Both share the feature that transaction price ≠ fair value at initial recognition – but the CAUSE differs CONCESSIONARY: an INTENDED non-exchange component (a deliberate transfer of resources built into below-market terms) ORIGINATED CREDIT-IMPAIRED: one or more events have ALREADY damaged the estimated future cash flows
First assess the loan's SUBSTANCE under IPSAS 28 and IPSAS 47 – is it a loan, a non-exchange transaction, a contribution from owners, or a combination? Then determine fair value at initial recognition – using an active market reference, or (more commonly) a valuation technique discounting future receipts at a MARKET-RELATED rate for a similar loan (paras. AG123–AG124). The transaction-price/fair-value DIFFERENCE: if the loan is RECEIVED, apply IPSAS 47; if GRANTED, expense it immediately (unless it's a transaction with owners in that capacity) (para. AG125).
13
Gains, Losses & Presentation (paras. 101–108)
Fair-value gains/losses – default to surplus/deficit, with four carve-outs
Default: SURPLUS OR DEFICIT. Carve-outs: (a) it's part of a hedging relationship; (b) an equity instrument with the §6 net-assets/equity election; (c) a fair-value-designated liability's OWN credit risk component; or (d) an FVNA/E debt asset's specific fair-value-change split (para. 101).
Amortized-cost gains/losses, and dividends
Recognized in surplus or deficit only on DERECOGNITION, RECLASSIFICATION, through the AMORTIZATION process, or to recognize IMPAIRMENT (para. 103) Dividends recognized in surplus or deficit only when: the right to receive is established, economic benefit inflow is PROBABLE, and the amount is RELIABLY measurable (para. 102)
Investments in equity instruments electing the net-assets/equity presentation (§6): the election is IRREVOCABLE, and gains/losses NEVER recycle to surplus/deficit – even on disposal (para. 106 and following, cross-ref IPSAS 28's treasury-share-style permanence).
14
Hedge Accounting – Objective, Instruments & Qualifying Criteria (paras. 113–129)
Objective, and the option to stay on IPSAS 29's model
Represents, in the financial statements, the effect of risk management activities using financial instruments against particular risks affecting surplus/deficit (or net assets/equity, for the elected equity-instrument category) (para. 113). An entity may instead ELECT to keep applying IPSAS 29's legacy hedge accounting model – see that Standard's own poster (para. 115, cross-ref).
Qualifying instruments, and designation rules
A DERIVATIVE at fair value through surplus or deficit may be a hedging instrument (except some written options) (para. 116) A NON-DERIVATIVE at fair value through surplus or deficit may also qualify – with a foreign-currency-risk-component carve-out for equity instruments on the net-assets/equity election (para. 117) Only EXTERNAL counterparty contracts qualify (para. 118) Must be designated in its ENTIRETY – narrow exceptions for intrinsic-value-only options, spot-element-only forwards, and PROPORTIONS of an instrument (para. 119)
The three qualifying criteria (para. 129) – ALL required
Consists ONLY of eligible hedging instruments and hedged items FORMAL designation and documentation at INCEPTION – instrument, hedged item, risk nature, and the effectiveness-assessment method (including sources of ineffectiveness and hedge-ratio determination) Meets hedge EFFECTIVENESS requirements: a genuine economic relationship; credit risk doesn't DOMINATE the value changes; and the hedge RATIO matches actual hedging activity (without artificial imbalance)
15
Hedge Accounting – the Three Hedge Types, Rebalancing & Discontinuation (paras. 130–135)
Three hedge types (para. 131)
Fair value hedge – exposure to fair value changes in a recognized asset/liability or unrecognized firm commitment, attributable to a specific risk affecting surplus/deficit Cash flow hedge – exposure to cash flow variability from a recognized item or highly probable forecast transaction Net investment hedge – as defined in IPSAS 4
A firm commitment's foreign currency risk hedge may be treated as EITHER fair value or cash flow (para. 133). Where the hedged item is a net-assets/equity-elected equity instrument, ineffectiveness is ALSO presented in net assets/equity (para. 132).
Rebalancing, and prospective-only discontinuation
If the hedge RATIO drifts out of qualification but the RISK MANAGEMENT OBJECTIVE stays the same → REBALANCE the ratio to re-qualify, rather than discontinuing (para. 134). Discontinuation is always PROSPECTIVE – only when the relationship (or part of it) genuinely stops meeting the qualifying criteria, including instrument expiry/sale/termination/exercise. A CLEARING-COUNTERPARTY NOVATION required by new laws/regulations is explicitly NOT treated as expiration/termination, provided changes are limited to effecting that replacement (para. 135) – mirroring IPSAS 29's own modernization for post-crisis derivatives clearing mandates.
16
Disclosure – Cross-Reference to IPSAS 30
Recognition/measurement here, disclosure there
IPSAS 41 governs recognition, classification, measurement, impairment, derecognition, and hedge accounting. ALL disclosure requirements for financial instruments – significance for financial position/performance, the expected-credit-loss disclosure package, credit/liquidity/market risk, and concessionary loan disclosures – live in IPSAS 30, Financial Instruments: Disclosures, not here. See that Standard's own poster for the complete disclosure package this Standard's classification and impairment mechanics feed directly into.
17
Effective Date & Amendment Timeline (paras. 156–156C)
Amendment history at a glance
Base Standard: periods beginning on/after 1 January 2023 – issued August 2018, replacing almost all of IPSAS 29's original content.
EffectiveChange
1 Jan 2023New paras. 185–190, AG74A; amended AG73(b), AG74(b) – Long-term Interests in Associates and Joint Ventures / Prepayment Features with Negative Compensation amendments (Jan 2019)
1 Jan 2023New paras. 72A–72E, 155M–155Z, 191–194 – Improvements to IPSAS, 2021 (further benchmark reform and ECL refinements)
18
Relationship to IFRS 9
Comparison – IPSAS 41 vs IFRS 9
IPSAS 41 is drawn primarily from IFRS 9 (amendments to 31 December 2015), Financial Instruments.
TopicDifference
Public-sector-specific guidanceIPSAS 41 adds application guidance for CONCESSIONARY LOANS (§12), financial guarantees at nil/nominal consideration, equity instruments from non-exchange transactions, and fair value measurement
Terminology"Statement of financial performance," "net assets/equity" (IPSAS 41) vs "statement of comprehensive income or separate income statement," "equity" (IFRS 9)
Revenue vs incomeIPSAS 41 does not distinguish them; IFRS 9 treats "income" as broader than "revenue"
Embedded IFRIC guidanceIFRIC 16 (Hedges of a Net Investment) and IFRIC 19 (Extinguishing Financial Liabilities with Equity Instruments) are AUTHORITATIVE appendices to IPSAS 41; under IFRS, these are separate documents
Fair value measurement guidanceIPSAS 41 retains ADDITIONAL fair value guidance carried over from IPSAS 29
19
Statement / Process Mapping
The master decision map
- Does the entity become party to the contract? → recognize at fair value ± transaction costs (§3)
- CLASSIFY: apply the management-model AND SPPI tests to assets (§6); apply the four-exception default for liabilities (§7)
- Is there an ACCOUNTING MISMATCH? → consider the fair value option override (§6, §7)
- Subsequently measure per classification – amortized cost via the effective interest method, or fair value (§9)
- For amortized-cost/FVNA/E assets: assess credit risk INCREASE each period → 12-month or lifetime ECL; apply the simplified approach where mandated (§10, §11)
- On transfer or extinguishment → apply the risks-and-rewards (assets) or extinguishment (liabilities) derecognition tests (§4, §5)
- Electing hedge accounting? → choose IPSAS 41's own model (§14–§15) OR the IPSAS 29 legacy alternative
- Route ALL disclosure requirements to IPSAS 30 (§16)
Concept-to-statement mapping table
IPSAS 41 conceptStatement(s)Notes
Amortized cost asset/liabilitySOFPEffective interest method
Fair value through surplus/deficitSOFP SOFPerfAll fair value changes to surplus/deficit
Fair value through net assets/equity (debt)SOFP NA/ERecycled to surplus/deficit on derecognition
Equity instrument NA/E electionNA/EIrrevocable, never recycled
Expected credit loss allowanceSOFPerfImpairment gain/loss each period
Cash flow hedge – effective portionNA/EIneffective portion to surplus/deficit
All disclosuresNotesPer IPSAS 30, not IPSAS 41 itself
20
Related Standards – Cross-Reference Map
How IPSAS 41 connects across the IPSAS body of literature
StandardNature of the connection
IPSAS 4Defines net investment hedges (§15); foreign exchange gain/loss guidance for settlement-date accounting (§4)
IPSAS 19Contingent liability recognition/measurement in an IPSAS 40 combination context; rights to reimbursement excluded from scope (§1)
IPSAS 20Key management personnel definition drives the fair-value-option-by-management-strategy test (§7)
IPSAS 28Equity instrument definitions; the entity's own equity instruments excluded from scope; concessionary loan substance test (§1, §12)
IPSAS 29The legacy hedge accounting alternative an entity may elect instead of §14–§15 (§14)
IPSAS 30Houses ALL disclosure requirements this Standard's mechanics feed into (§16)
IPSAS 32Grantor financial liability model derecognition governed here (§1)
IPSAS 39Qualifying insurance policies and other plan-asset financial instruments
IPSAS 40Contingent consideration measurement; classification/designation carryover rules for combinations (§7)
IPSAS 43Lease receivable derecognition/impairment; lessee lease liability derecognition (§1)
IPSAS 46Fair value measurement methodology underpinning the entire Standard (§9)
IPSAS 47Governs the significant financing component test for the simplified ECL approach; non-exchange components of concessionary loans (§11, §12)
21
Quick-Reference Glossary
Amortized cost
Initial measurement, less principal repayments, plus/minus cumulative effective-interest amortization, adjusted for loss allowance.
SPPI test
Whether contractual cash flows are solely payments of principal and interest on the outstanding principal amount.
Expected credit losses
A probability-weighted estimate of credit losses over either 12 months or the instrument's lifetime.
Concessionary loan
A loan granted or received at below-market terms, with a deliberate non-exchange component built in from the outset.
Derecognition
The removal of a previously recognized financial asset or liability from the statement of financial position.
Hedge ratio
The relationship between the quantity of the hedged item and the quantity of the hedging instrument actually used.
Financial statement key
SOFP Statement of financial position
SOFPerf Statement of financial performance
NA/E Net assets/equity (statement of changes)
Notes Notes to the financial statements